ES484150A1 - Procedimiento para la preparacion de derivados de tiadiazol - Google Patents

Procedimiento para la preparacion de derivados de tiadiazol

Info

Publication number
ES484150A1
ES484150A1 ES484150A ES484150A ES484150A1 ES 484150 A1 ES484150 A1 ES 484150A1 ES 484150 A ES484150 A ES 484150A ES 484150 A ES484150 A ES 484150A ES 484150 A1 ES484150 A1 ES 484150A1
Authority
ES
Spain
Prior art keywords
radical
sup
sub
carbon atoms
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES484150A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Zeneca Inc
Original Assignee
Imperial Chemical Industries Ltd
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd, ICI Americas Inc filed Critical Imperial Chemical Industries Ltd
Publication of ES484150A1 publication Critical patent/ES484150A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)

Abstract

Procedimiento para la preparación de derivados de tiadiazol, de fórmula: **(fórmula)** en donde Y es un átomo de oxígeno o azufre, un enlace directo o un radical metileno o sulfinilo; m es 0 a 4 y n es 1 a 4, con la condición de que, cuando Y es un átomo de azufre u oxígeno o un radical sulfinilo m es 1 a 4, y cuando Y es un átomo de oxígeno o un radical sulfinilo n es 2 a 4; r{sup,1} es un átomo de hidrógeno o un radical alquilo de 1 a 10 átomos de carbono; A es un radical 3,4-dioxociclobuten-1,2-diilo o un radical de fórmula NCN, NNO{sub,2}, CHNO{sub,2}, NCONH{sub,2}, C(CN){sub,2}, NCOR{sup,2}, NCO{sub,2}R{sup,2}, NSO{sub,2}R{sup,2} o NR{sup,3} en donde R{sup,2} es un radical alquilo de 1 a 6 átomos de carbono o un radical arilo de 6 a 12 átomos de carbono y R{sup,3} es un átomo de hidrógeno o un radical alquilo de 1 a 6 átomos de carbono; B es un radical alcoxi o alquiltio de 1 a 6 átomos de carbono o un radical de fórmula NR{sup,4}R{sub,5}.
ES484150A 1978-05-24 1979-09-13 Procedimiento para la preparacion de derivados de tiadiazol Expired ES484150A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2173778 1978-05-24

Publications (1)

Publication Number Publication Date
ES484150A1 true ES484150A1 (es) 1980-04-16

Family

ID=10167957

Family Applications (3)

Application Number Title Priority Date Filing Date
ES480894A Expired ES480894A1 (es) 1978-05-24 1979-05-24 Procedimiento para la preparacion de derivados de tiadiazol.
ES484149A Expired ES484149A1 (es) 1978-05-24 1979-09-13 Procedimiento para la preparacion de un derivado de tiadia- zol
ES484150A Expired ES484150A1 (es) 1978-05-24 1979-09-13 Procedimiento para la preparacion de derivados de tiadiazol

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES480894A Expired ES480894A1 (es) 1978-05-24 1979-05-24 Procedimiento para la preparacion de derivados de tiadiazol.
ES484149A Expired ES484149A1 (es) 1978-05-24 1979-09-13 Procedimiento para la preparacion de un derivado de tiadia- zol

Country Status (22)

Country Link
US (2) US4242350A (es)
EP (1) EP0006679B1 (es)
JP (1) JPS54160376A (es)
AT (1) ATE1353T1 (es)
AU (1) AU529253B2 (es)
CA (1) CA1124729A (es)
CS (2) CS207791B2 (es)
DD (1) DD143772A5 (es)
DE (1) DE2963363D1 (es)
DK (1) DK209079A (es)
ES (3) ES480894A1 (es)
FI (1) FI791656A7 (es)
GR (1) GR73611B (es)
HU (1) HU179492B (es)
IE (1) IE48221B1 (es)
IL (1) IL57388A0 (es)
NO (1) NO791710L (es)
NZ (1) NZ190448A (es)
PL (1) PL118387B1 (es)
PT (1) PT69651A (es)
SU (1) SU1037839A3 (es)
ZA (1) ZA792202B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE1353T1 (de) * 1978-05-24 1982-08-15 Imperial Chemical Industries Plc Anti-sekretion thiadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0014057B1 (en) * 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
GR71929B (es) * 1979-11-13 1983-08-19 Ici Ltd
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
DE3270716D1 (en) * 1981-02-27 1986-05-28 Ici Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
CA1209998A (en) * 1981-03-09 1986-08-19 David J. Gilman Amide derivatives as histamine h-2 receptor antagonists
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
US4460584A (en) * 1981-03-13 1984-07-17 Imperial Chemical Industries Plc Nitrogen heterocycles
IN158869B (es) * 1981-03-18 1987-02-07 Ici Plc
US4463005A (en) * 1981-03-18 1984-07-31 Imperial Chemical Industries Plc Bicyclic guanidines
US4451463A (en) * 1981-03-24 1984-05-29 Imperial Chemical Industries Plc Alcohol derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
US4546188A (en) * 1981-05-18 1985-10-08 Bristol-Myers Company Substituted 1,2-diaminocyclobutene-3,4-diones
US4395553A (en) * 1981-05-18 1983-07-26 Bristol-Myers Company Chemical compounds
US4522943A (en) * 1981-05-18 1985-06-11 Bristol-Myers Company Chemical compounds
US4526973A (en) * 1981-05-18 1985-07-02 Bristol-Myers Company Chemical compounds
US4607105A (en) * 1981-05-18 1986-08-19 Bristol-Myers Company 3-cyclobutene-1,2-dione intermediates
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
US4539316A (en) * 1981-05-18 1985-09-03 Bristol-Myers Company Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones
EP0067508B1 (en) * 1981-05-18 1985-10-30 Imperial Chemical Industries Plc Amidine derivatives
GB8419223D0 (en) * 1984-07-27 1984-08-30 Hoechst Uk Ltd Sulphamoylguanidine derivatives
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
RU2348623C1 (ru) * 2007-05-21 2009-03-10 Государственное образовательное учреждение высшего профессионального образования "Ивановский государственный химико-технологический университет" (ИГХТУ) Способ получения 3,5-диамино-1,2,4-тиадиазола
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE842346C (de) * 1950-10-14 1952-06-26 Joachim Dipl-Chem Dr Goerdeler Verfahren zur Darstellung von 5-Amino-1, 2, 4-thiodiazolen
DE955684C (de) * 1953-10-14 1957-01-10 Bayer Ag Verfahren zur Herstellung von 5-Amino-1, 2, 4-thiodiazolen
NL266116A (es) 1960-06-22
BE758146A (fr) 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
GB1305549A (es) 1969-10-29 1973-02-07
GB1338169A (en) 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1400319A (en) 1972-04-20 1975-07-16 Smith Kline French Lab Pharmaceutical compositions
GB1398426A (en) 1972-09-05 1975-06-18 Smith Kline French Lab Heterocyclic substituted guanidines
GB1397436A (en) 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1421999A (en) 1973-02-08 1976-01-21 Smith Kline French Lab Heterocyclic containing sulphoxides
GB1419994A (en) 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB1421792A (en) 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1497260A (en) 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives
GB1531231A (en) 1974-09-02 1978-11-08 Smith Kline French Lab Process for the production of cyanoguanidine derivatives
GB1533379A (en) 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted ureas
GB1533380A (en) 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines
GB1574214A (en) 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
IE47044B1 (en) * 1977-04-20 1983-12-14 Ici Ltd Guanidine derivatives
ATE1353T1 (de) * 1978-05-24 1982-08-15 Imperial Chemical Industries Plc Anti-sekretion thiadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
NZ190448A (en) 1980-12-19
EP0006679A1 (en) 1980-01-09
JPS54160376A (en) 1979-12-19
FI791656A7 (fi) 1981-01-01
SU1037839A3 (ru) 1983-08-23
IL57388A0 (en) 1979-09-30
ES484149A1 (es) 1980-04-16
CS207791B2 (en) 1981-08-31
PL118387B1 (en) 1981-09-30
NO791710L (no) 1979-11-27
HU179492B (en) 1982-10-28
PT69651A (en) 1979-06-01
US4242350A (en) 1980-12-30
IE790902L (en) 1979-11-24
ATE1353T1 (de) 1982-08-15
CA1124729A (en) 1982-06-01
DD143772A5 (de) 1980-09-10
AU529253B2 (en) 1983-06-02
EP0006679B1 (en) 1982-07-21
CS207790B2 (en) 1981-08-31
AU4711479A (en) 1979-11-29
IE48221B1 (en) 1984-10-31
DK209079A (da) 1979-11-25
PL215764A1 (es) 1980-06-16
GR73611B (es) 1984-03-26
ZA792202B (en) 1980-05-28
DE2963363D1 (en) 1982-09-09
US4332949A (en) 1982-06-01
ES480894A1 (es) 1980-02-01

Similar Documents

Publication Publication Date Title
ES484150A1 (es) Procedimiento para la preparacion de derivados de tiadiazol
ES455149A1 (es) Procedimiento para preparar n-fenil-n'-benzoil-ureas.
ES8506612A1 (es) Un metodo para producir un derivado de amina
DK443488A (da) Hidtil ukendt overfladebehandling
ES449418A1 (es) Procedimiento para la obtencion de imidazolil-o, n-acetales.
ES510585A0 (es) Procedimiento para preparar n-heterociclilmetilamidas.
GB1008264A (en) Benzoxazole derivatives
DE3372364D1 (en) 1-carboxyalkanoylperhydroindole-2-carboxylic acids and derivatives
IE36221B1 (en) Acylamino compounds and a process for their manufacture
UA7051A1 (uk) N-[6-метоксі-5-(перфторалкін)-1-нафтоіл]-n-метілгліцин чи його тіонафтоільні аналоги як інгібітори албдозоредуктази
DE2962500D1 (en) Antisecretory oxadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
YU47010B (sh) Derivati 1,6-naftiridina
ES480603A1 (es) Un procedimiento para la preparacion de nuevos derivados de indol.
ES2061556T3 (es) Derivados amida y su produccion y fungicidas agricolas que los contienen.
ATE38665T1 (de) Verfahren zur herstellung von 5-perfluoralkyl-5,6-dihydrouracyl-derivaten und verwendbare zwischenprodukte.
ES481119A1 (es) Procedimiento para preparar compuestos nitro.
GB1497590A (en) Compositions based on sulphoxide derivatives of cysteamin
IE45092L (en) Carbamic acid oxime-esters.
ES453121A1 (es) Un metodo de preparacion de nuevos derivados de piridil u- reas.
FR2529891B1 (es)
DE68924010D1 (de) Verfahren zur Herstellung von 1-alpha,3-beta,24-Trihydroxy-delta-5-Steroidderivaten.
FR2494272B1 (es)
ES461252A1 (es) Un procedimiento para la produccion de 4,5-epoxi-tetrahidro-piran-3-ona.
ES485990A1 (es) Procedimiento de preparacion de un nuevo derivado de la per-hidrotiazina-1,3
ATE19881T1 (de) Tropyl- und pseudotropylalkylbenzoate und ihre verwendung in der behandlung von migraene.